Aurora Cannabis

ACB Stock: It's Not Too Late to Cash Out of Aurora Cannabis

ACB stock is down big in the past month, but investors shouldn't feel like they missed out on a chance to cash in on big post-election gains. - March 08, 2021

Tilray Beats Canopy Growth and Aurora Cannabis to Profitability | The Motley Fool

But is that enough of a reason to invest in the company? - March 03, 2021

Why Aphria, Canopy Growth, and Aurora Cannabis Stocks Jumped Today | The Motley Fool

Cannabis company stocks are getting a boost after another U.S. state passed legalization legislation. - March 01, 2021

Is Aurora Cannabis Stock a Buy? | The Motley Fool

The cannabis producer has been making progress -- but is it enough to win over hesitant investors? - February 24, 2021

Why Sundial, Aurora Cannabis, Aphria, and Other Marijuana Stocks Plunged Today | The Motley Fool

Pot stocks surrendered some of their recent gains amid a broad market sell-off. - February 23, 2021

Where Will Aurora Cannabis Be in 1 Year? | The Motley Fool

After doing some good on its promise of a comeback, Aurora has encountered yet another roadblock. - February 23, 2021

Aurora Cannabis Is Speculative -- And It Might Take a Breather Soon

The ACB stock price has gone sky-high in 2021, but Q2 results showed little fundamental reason to support further gains. - February 20, 2021

Until Aurora Cannabis Gets Profitable, ACB Stock Is Stuck in a Rut

ACB stock won’t get a major boost until Aurora Cannabis can report positive free cash flow. Here's what investors should do with ACB stock. - February 19, 2021

Aurora Cannabis Stock: It’s Too…High?

Thanks to some new partnerships and the Reddit market frenzy, ACB stock experienced a nice bump. That doesn't mean it's sustainable. - February 18, 2021

Why Marijuana Stocks Like Aurora Cannabis and HEXO Are Sinking Today | The Motley Fool

Investors, it seems, are sobering up about the weed industry after pushing its stocks high over the past few days. - February 17, 2021

Why Aurora Cannabis Stock Popped Double Digits Today | The Motley Fool

More consolidation in the sector and large pension fund investment have investors betting on Aurora. - February 16, 2021

Why Aurora Cannabis, OrganiGram Holdings, and HEXO Dropped, Then Bounced Friday | The Motley Fool

Volatility continues in cannabis stocks as quarterly earnings begin to filter in. - February 12, 2021

Should You Sell Aurora Cannabis Stock? | The Motley Fool

One analyst says the marijuana company's investors could incur brutal losses. - February 12, 2021

Why Aurora Cannabis, Aphria, Cronos Group, and Other Marijuana Stocks Crashed Today | The Motley Fool

Traders are bailing out of pot stocks. But should they be? - February 11, 2021

Aurora Cannabis Pops After Hours on Second-Quarter Results | The Motley Fool

The company showed encouraging growth in the stronger of its two main product categories. - February 11, 2021

Why Canopy Growth, Aurora Cannabis, and Hexo Stocks Are Still Flying High | The Motley Fool

Analysts seem confused about whether Canopy's Q3 earnings were good or bad. - February 10, 2021

Why Aurora Cannabis Has a Bearish Stock Forecast in 2021

Aurora Cannabis (ACB) has a bearish stock forecast in 2021. However, investors have defied Wall Street's bearishness and pushed the stock higher. - February 10, 2021

Why Canopy Growth, Aurora Cannabis, and HEXO Stocks Are Up Today | The Motley Fool

Canopy promises investors a profit, but didn't quite deliver it this time. - February 09, 2021

Can Aurora Cannabis Stock Bounce Back In 2021? | The Motley Fool

Its stock price has gone sky high so far this year -- but has Aurora really done anything to merit the boost, or is it a fluke? - February 09, 2021

Aurora Cannabis Stock Is Worthy of a Small Pre-Earnings Investment

There's no need to load the boat on ACB stock now. Instead, consider trying out a small position in hopes of full U.S. cannabis legalization. - February 08, 2021

Investors Seem a Little Too Excited About Aurora Cannabis

ACB stock has soared amid investor hopes for a turnaround under new management. But debt, dilution, and market share remain serious problems. - February 08, 2021